Author/Editor		Rizvi, Ali A.; Kathuria, Amita; Mahmeed, Wael Al; Al-Rasadi, Khalid; Al-Alawi, Kamila; Banach, Maciej; Banerjee, Yajnavalka; Ceriello, Antonio; Cesur, Mustafa; Janež, Andrej
Title		Post-COVID syndrome, inflammation, and diabetes
Type		članek
Publication year		2022
Volume		str. str.
ISSN		1056-8727 - Journal of diabetes and its complications
Language		eng
Abstract		The raging COVID-19 pandemic is in its third year of global impact. The SARS CoV 2 virus has a high rate of spread, protean manifestations, and a high morbidity and mortality in individuals with predisposing risk factors. The pathophysiologic mechanisms involve a heightened systemic inflammatory state, cardiometabolic derangements, and varying degrees of glucose intolerance. The latter can be evident as significant hyperglycemia leading to new-onset diabetes or worsening of preexisting disease. Unfortunately, the clinical course beyond the acute phase of the illness may persist in the form of a variety of symptoms that together form the so-called “Long COVID” or “Post-COVID Syndrome”. It is thought that a chronic, low-grade inflammatory and immunologic state persists during this phase, which may last for weeks or months. Although numerous insights have been gained into COVID-related hyperglycemia and diabetes, its prediction, course, and management remain to be fully elucidated.
Keywords		COVID-19 type 2 diabetes post-COVID syndrome COVID-19 sladkorna bolezen tipa 2 post-COVID sindrom